Josef Pannee

Proteomics profiling of single organs from individual adult zebrafish.

SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration.

Multiplexing and multivariate analysis in neurodegeneration.

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

Specific Triazine Herbicides Induce Amyloid-β42 Production.

Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.